Salmeterol Xinafoate [salmeterol xinafoát]
topical
11
- Terms
-
salmeterol
salmeterol-xinafoát
Serevent Diskus
-
Salmeterol
Serevent
Persistent link
https://www.medvik.cz/link/D000068299
Definition
A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a BRONCHODILATOR when administered by inhalation. It is used to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
- DUI
- D000068299 MeSH Browser
- CUI
- M000602359
- History note
- 2016 (1989)
- Public note
- 2016; SALMETEROL XINAFOATE was indexed under ALBUTEROL 1989-2015
Allowable subheadings
- AD
- administration & dosage 3
- AE
- adverse effects 0
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 0
- HI
- history 1
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 2
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 10
- TO
- toxicity 0
- UR
- urine 0
...
Occurrences in Medvik records
D
Chemicals and Drugs
D02.033.100.291.057.125
Albuterol, Ipratropium Drug Combination
D02.033.100.291.057.500
Levalbuterol
D02.092.063.291.057.125
Albuterol, Ipratropium Drug Combination
D02.092.063.291.057.500
Levalbuterol
D02.092.471.683.061.125
Albuterol, Ipratropium Drug Combination
D02.092.471.683.061.500
Levalbuterol